市場調查報告書
商品編碼
1451865
足下垂植入物市場報告(按產品(功能性電刺激器、內固定裝置)、最終用戶(醫院、安寧療護中心、骨科中心等)和地區)2024-2032Foot Drop Implants Market Report by Product (Functional Electrical Stimulators, Internal Fixation Devices), End User (Hospitals, Palliative Care Centers, Orthopedic Centers, and Others), and Region 2024-2032 |
2023年,全球足下垂植入物市場規模達到40億美元。展望未來, IMARC Group預計到2032年市場規模將達到72億美元,2024-2032年複合年成長率(CAGR)為6.46%。足下垂和神經系統疾病盛行率的上升、老年人口的擴大、對個人化治療解決方案的需求不斷增加以及植入物設計和材料的技術進步是推動市場的一些關鍵因素。
足下垂是指一種以前腳下垂或抬起腳前部困難為特徵的神經系統疾病。它通常是由於腓總神經受損、控制腳踝和足部運動的肌肉無力或癱瘓,或中風、多發性硬化症和腦性麻痺等損傷和病症而發生。它可能導致正常行走困難或偏離,並且通常與步態和背屈等症狀有關。足下垂植入物是一種醫療設備,旨在透過更換或加固受損部件來減少這種情況造成的功能限制。它們為腳踝和足部提供穩定性和支撐,使患者能夠重新獲得活動能力並輕鬆地進行日常活動,同時提高他們的生活品質。因此,食物滴植入物在整個醫療保健行業中越來越受歡迎,用於恢復功能並促進患者更自然的步態。
由於神經損傷、運動相關損傷和道路事故的病例不斷增加,足下垂的盛行率不斷上升,這是支持市場成長的主要因素之一。此外,越來越多的老年人口更容易患上這種疾病,導致全球範圍內對足下垂植入物的需求更高。此外,足下垂治療已顯著轉向微創 (MI) 外科手術,因為它們恢復時間更短、疤痕和切口更少,並降低了併發症的風險。與此一致的是,擴大利用外科足下垂植入物來提供直接機械支撐和恢復肌肉功能,從而加快了產品的採用率。此外,領先的製造商正致力於推出新型植入物變體,以提供更好的穩定性、支撐、舒適性和易用性。此類產品創新正在改善患者的治療效果和滿意度,從而推動市場成長。除此之外,輕鬆獲得有利的報銷政策以及對個人化治療方案不斷成長的需求正在促進市場成長。其他因素,包括神經系統疾病發病率上升、醫療基礎設施改善、醫療保健支出增加、植入物設計和材料的技術進步以及持續的研發 (R&D) 活動,預計也將推動未來幾年的市場成長。
The global foot drop implants market size reached US$ 4.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 7.2 Billion by 2032, exhibiting a growth rate (CAGR) of 6.46% during 2024-2032. The rising prevalence of foot drop and neurological disorders, expanding geriatric population, escalating demand for personalized treatment solutions, and technological advancements in implant design and materials represent some of the key factors driving the market.
Foot drop refers to a neurological disorder characterized by the dropping of the forefoot or difficulty in lifting the front part of the foot. It usually occurs due to damage to the common fibular nerve, weakness or paralysis of the muscles that control the ankle and foot movement, or injuries and conditions such as stroke, multiple sclerosis, and cerebral palsy. It can lead to difficulty or deviation from normal walking and is commonly associated with symptoms such as steppage gait and dorsiflexion. Foot drop implants are medical devices designed to reduce the functional limitations caused by this condition by replacing or reinforcing the damaged part. They provide stability and support to the ankle and foot, allowing patients to regain mobility and perform daily activities easily while improving the quality of their lives. As a result, food drop implants are gaining immense popularity across the healthcare industry for restoring function and facilitating a more natural gait in patients.
The rising prevalence of foot drop owing to the increasing cases of nerve damage, sports-related injuries, and road accidents represents one of the primary factors supporting the market growth. Moreover, the expanding geriatric population that is more susceptible to developing this condition is leading to a higher demand for foot drop implants across the globe. Additionally, there has been a significant shift toward minimally invasive (MI) surgical procedures for foot drop treatment as they offer a shorter recovery period, less scarring and incision, and reduced risk of complications. In line with this, the growing utilization of surgical foot drop implants to provide direct mechanical support and restore muscle function has accelerated product adoption rates. Furthermore, the leading manufacturers are focusing on the launch of novel implant variants that offer better stability, support, comfort, and ease of use. Such product innovations are improving patient outcomes and satisfaction, thereby propelling market growth. Besides this, the easy availability of favorable reimbursement policies and the escalating demand for personalized treatment options are augmenting market growth. Other factors, including the rising incidences of neurological disorders, improving medical infrastructure, increasing healthcare expenditure, technological advancements in implant design and materials, and ongoing research and development (R&D) activities, are also anticipated to fuel market growth in the coming years.
IMARC Group provides an analysis of the key trends in each segment of the global foot drop implants market, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on product and end user.
Functional Electrical Stimulators
Internal Fixation Devices
The report has provided a detailed breakup and analysis of the foot drop implants market based on the product. This includes functional electrical stimulators and internal fixation devices. According to the report, internal fixation devices represented the largest segment.
Hospitals
Palliative Care Centers
Orthopedic Centers
Others
A detailed breakup and analysis of the foot drop implants market based on the end user has also been provided in the report. This includes hospitals, palliative care centers, orthopedic centers, and others. According to the report, hospitals accounted for the largest market share.
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for foot drop implants. Some of the factors driving the North America foot drop implants market included the growing burden of neurological conditions, rapidly aging population, continuous technological advancements and product launches by key players, etc.
The report has also provided a comprehensive analysis of the competitive landscape in the global foot drop implants market. Detailed profiles of all major companies have been provided. Some of the companies covered include aap Implantate AG, Acumed LLC (Colson Medical LLC), Arthrex Inc., Bioness Inc. (Bioventus Inc.), Narang Medical Limited, Ottobock SE & Co. KGaA, Stryker Corporation, Zimmer Biomet, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.